NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NVision

NVision

Private
UlmHealthcare & Life Scienceshttps://www.nvision-quantum.com/

Last Round

Series B

May 13, 2026

Est. Valuation

$2B

Total Funding Raised

$404.1M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NVision Quantum Technologies is a healthcare technology company that develops quantum-based sensing and computing platforms for medical imaging and drug development.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Drug Discovery, Quantum Computing, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

quantum sensingmedical imagingdrug discoveryquantum computingMRI enhancementhyperpolarizationphotonic integrated circuitsPIQCmetabolic imagingquantum hardwarebiotech hardwaredeep techquantum biotechmolecular simulationlab-to-clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NVision Comps

Public and private peers based on sector, stage, and business model.

NVision comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 13, 2026
Series FDec 11, 2018
Series ENov 1, 2017
Series DJun 21, 2016
Series CJul 14, 2015
Series B
Aug 6, 2014

NVision Investors

Notable investors and investment history

NVision investors
InvestorRounds
Geodesic CapitalSeries F, Series E
Entrée CapitalSeries B
FirstMark CapitalSeries C, Series B, Series D, Series F, Series A, Series E, Seed
ICONIQ CapitalSeries F, Series E, Series D
European Investment Bank GroupSeries B
Matterwave VenturesSeries B
CDP Venture Capital SGRSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    $55M round led by Abbott Laboratories

  • Dec 11, 2018

    $115M round led by Spark Capital.

NVision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersUlm
Year Founded2015
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.